Impact of ADA Guidelines and Medication Shortage on GLP-1 Receptor Agonists Prescribing Trends in the UK: A Time-Series Analysis with Country-Specific Insights.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Impact of ADA Guidelines and Medication Shortage on GLP-1 Receptor Agonists Prescribing Trends in the UK: A Time-Series Analysis with Country-Specific Insights.
- Published In:
- Journal of clinical medicine, 13(20) (2024)
- Authors:
- Ibrahim, Ahmed R N, Orayj, Khalid M
- Database ID:
- RPEP-08427
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08427APA
Ibrahim, Ahmed R N; Orayj, Khalid M. (2024). Impact of ADA Guidelines and Medication Shortage on GLP-1 Receptor Agonists Prescribing Trends in the UK: A Time-Series Analysis with Country-Specific Insights.. Journal of clinical medicine, 13(20). https://doi.org/10.3390/jcm13206256
MLA
Ibrahim, Ahmed R N, et al. "Impact of ADA Guidelines and Medication Shortage on GLP-1 Receptor Agonists Prescribing Trends in the UK: A Time-Series Analysis with Country-Specific Insights.." Journal of clinical medicine, 2024. https://doi.org/10.3390/jcm13206256
RethinkPeptides
RethinkPeptides Research Database. "Impact of ADA Guidelines and Medication Shortage on GLP-1 Re..." RPEP-08427. Retrieved from https://rethinkpeptides.com/research/ibrahim-2024-impact-of-ada-guidelines
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.